Pregnancy Outcomes in Patients Exposed to Intramuscular Interferon beta-1a (IM IFNβ-1a)

被引：0
|
作者：
Tomczyk, Sylvie [1 ]
Sperling, Bjorn [2 ]
机构：
[1] Biogen Idec Inc, Cambridge, MA USA
[2] Biogen Idec Inc, Weston, MA USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S30006
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics and Pharmacodynamics of Interferon Beta-la (IFNβ-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration
    John Alam
    Arthur McAllister
    James Scaramucci
    Wendy Jones
    Mark Rogge
    Clinical Drug Investigation, 1997, 14 : 35 - 43
  • [42] Effects of statins on intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis
    Rudick, R.
    Pace, A.
    Panzara, M.
    Rani, S.
    Schrock, J.
    Calabresi, F.
    Confavreux, C.
    Galetta, S.
    Lublin, F.
    Radue, E. W.
    Stuart, W.
    Weinstock-Guttman, B.
    Wynn, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S57 - S57
  • [43] Comparing the outcomes of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 inpatients
    Seyfi, Shahram
    Latifi, Kayvan
    Male, Parviz Amri
    Zavareh, Mahmoud Sadeghi Haddad
    Ezoji, Khadijeh
    Mohammadnia-Afrozi, Mousa
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [44] Examination of quality of life in RRMS patients during the first year of treatment with interferon beta-1a (IM)
    Putzki, Norman
    Schicklmaier, Petra
    Niemczyk, Gabriele
    Hartung, Hans
    NEUROLOGY, 2008, 70 (11) : A271 - A271
  • [45] Efficacy and Safety of Daclizumab Beta Vs Intramuscular Interferon Beta-1a in Patients Previously Treated with Glatiramer Acetate in the Decide Study
    Khatri, Bhupendra
    Cohan, Stanley
    Ziemssen, Tjalf
    Ford, Corey
    Arnold, Douglas L.
    Robinson, Randy R.
    Riester, Katherine
    Fam, Sami
    Giannattasio, Giorgio
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 30 - 30
  • [46] MxA protein induction in MS patients treated with intramuscular IFNβ-1a
    A. M. Vallittu
    A. A. Salmi
    J. P. Erälinna
    Neurological Sciences, 2006, 26 : 438 - 443
  • [47] A Matching-adjusted Indirect Comparison of Clinical Effectiveness of Subcutaneous Peginterferon Beta-1a and Intramuscular Interferon Beta-1a for the Treatment of Relapsing Multiple Sclerosis
    You, Xiaojun
    Scott, Thomas
    Shang, Shulian
    Evilevitch, Vladimir
    Sabetella, Guido
    Werneburg, Brian
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 415 - 415
  • [48] Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients
    Rudick, R. A.
    Kappos, L.
    Kinkel, R.
    Clanet, M.
    Phillips, J. T.
    Herndon, R. M.
    Sandrock, A. W.
    Munschauer, F. E., III
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (03) : 353 - 360
  • [49] MxA protein induction in MS patients treated with intramuscular IFNβ-1a
    Vallittu, AM
    Salmi, AA
    Erälinna, JP
    NEUROLOGICAL SCIENCES, 2006, 26 (06) : 438 - 443
  • [50] FDA approves IFN beta-1a for MS
    不详
    BIOTECHNOLOGY LAW REPORT, 1996, 15 (05): : 700 - 700
12345